Submission Information

SUBMISSION INFORMATION

Please register or login to submit a manuscript or feature to the journal.

Peer review policy

All manuscripts submitted for publication undergo peer review. BHTY‘s editorial team strives to ensure that peer review is fair, unbiased, timely. Material submitted to BHTY remains confidential while under review. 

Article types

Research: Quantitative, qualitative, and mixed-model original research approaches that focus on blockchain technology and must contain a hypothesis, introduction, methods, results, interpretation of findings, and a discussion of possible implications.  Randomized, controlled trials, case series, cohort studies, pilot studies, and meta-analysis are also examples of original research that BHTY accepts for this category. As applicable, financial, and quality of care implications should also be explored. Maximum word count is 4000.

Methodology: Detailed outlines of mature, but unexecuted research protocols, current methodological approaches, grant proposals, and preliminary reports. Articles must contain background, objectives, methods, and discussion.  Maximum word count is 2000.

Proof of Concept: Demonstrations of blockchain technology feasibility to verify real world application, potential value and learnings. Examples such as interoperability, API, and system integration and deployment may be topics. Use cases may also be submitted under this category. As possible, BHTY asks the author(s) to include examination of the financial impact the product or service may have on the marketplace. Maximum word count is 2800.

Review: Narrative and systematic review articles provide an overview of existing literature focused on blockchain, distributed ledgers, and distributed systems. Example focal points include trust, identity, privacy, safety and security implications in healthcare and potential for blockchain to address these areas for devices, software, distribution channels, etc. The goal of this article type is to identify specific problems or issues and analyze information from available published work on the topic with a balanced perspective. Note: meta-analyses should be submitted as original research. Maximum word count for review articles is 4000.

Primers: Since the blockchain technology sector is relatively new, we recognize Primers can be an important source of basic information to help educate the marketplace, including device manufacturers, software providers, patients and providers, healthcare administrators and provide a launch point for understanding the complexities in related areas BHTY elucidates in more depth. Maximum word count is 2000.

Technological Report: These reports focus on blockchain technological innovations in healthcare. Priority is given to papers on the technical underpinnings of an initiative presented in a manner that informs influencers in making decisions in this space. For example, relevant pragmatic work on change management, human factors, and design thinking that accompany innovation should include actual implementation experience whenever available. Reports of metrics to measure these components is highly recommended. Maximum word count is 2000.

Perspective: These articles represent an expert opinion or considered point of view on the field of blockchain technology in healthcare, alerts of potential problems, observations, comments, controversies and opinions. It can contain a single concept or several related concepts. Maximum word count is 1000.

Disclosure of Unlabeled Use

Articles published by BHTY may contain information and discussions of published and/or investigational uses of devices and agents that are not indicated by the Food and Drug Administrations (FDA).  Partners in Digital Health do not recommend the use of any devices or agents outside of the labeled indications.

Authorship and related information

Manuscripts should only be submitted for consideration once authorization of all contributing authors is gathered. The list of authors will include those who can legitimately claim authorship. This includes all those who:

  1. Have made a substantial contribution to the concept and design, acquisition of data or analysis and interpretation of data
  2. Drafted the article or revised it critically for important intellectual content
  3. Approved the version to be published

Authors will meet the conditions of all of the points above. Each author will have participated sufficiently in the work to take public responsibility for appropriate portions of the content.

Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information.

The International Committee of Medical Journal Editors (ICMJE) has published the “Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals” (ICMJE Recommendations, formerly “Uniform Requirements for Manuscripts”). More information is here.

Patient consent

Authors will ensure the following guidelines are followed, as recommended by ICMJE, Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients’ names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published.

Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is usually inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. When informed consent has been obtained it should be indicated in the submitted article.

Statistical analyses

Ensure that the methodology has been accurately described for statistical analysis. In comparative studies power calculations are usually required. In research manuscripts requiring complex statistics the advice of an expert statistician should be sought at the design/implementation stage of the study. It may be appropriate to include them as a co-author.

If preparing statistical data for publication, please read the statistical guidelines. 

Corresponding author contact details

Provide full contact details for the corresponding author including email, mailing address, and telephone numbers. Academic affiliations are required for all authors. These details should be presented separately to the main text of the article to facilitate anonymous peer review.

Proofs and Reprints

PDF proofs will be sent to the corresponding author, who should send corrections as soon as the PDF is received. These corrections should be returned to the Managing Editor, John Russo Jr., PharmD.

Order forms for reprints will be emailed to the corresponding author shortly before publication of the article.

Submitted manuscripts should be exclusive publication in BHTY, with the understanding they have not been published elsewhere in any form and will not be submitted elsewhere unless rejected by BHTY. Authors are responsible for all statements made in the article and the veracity of the references cited.